Kaikkonen MU - Search Results

1

Single-Cell Epigenomics and Functional Fine-Mapping of Atherosclerosis GWAS Loci.

Örd T, Õunap K, Stolze LK, Aherrahrou R, Nurminen V, Toropainen A, Selvarajan I, Lönnberg T, Aavik E, Ylä-Herttuala S, Civelek M, Romanoski CE, Kaikkonen MU. Örd T, et al. Among authors: kaikkonen mu. Circ Res. 2021 Jul 9;129(2):240-258. doi: 10.1161/CIRCRESAHA.121.318971. Epub 2021 May 24. Circ Res. 2021. PMID: 34024118 Free PMC article.

2

Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo.

Kaikkonen MU, Räty JK, Airenne KJ, Wirth T, Heikura T, Ylä-Herttuala S. Kaikkonen MU, et al. Gene Ther. 2006 Feb;13(4):304-12. doi: 10.1038/sj.gt.3302657. Gene Ther. 2006. PMID: 16267571

3

Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells.

Mähönen AJ, Airenne KJ, Purola S, Peltomaa E, Kaikkonen MU, Riekkinen MS, Heikura T, Kinnunen K, Roschier MM, Wirth T, Ylä-Herttuala S. Mähönen AJ, et al. Among authors: kaikkonen mu. J Biotechnol. 2007 Aug 1;131(1):1-8. doi: 10.1016/j.jbiotec.2007.05.022. Epub 2007 May 31. J Biotechnol. 2007. PMID: 17617485

4

Targeting and purification of metabolically biotinylated baculovirus.

Kaikkonen MU, Viholainen JI, Närvänen A, Ylä-Herttuala S, Airenne KJ. Kaikkonen MU, et al. Hum Gene Ther. 2008 Jun;19(6):589-600. doi: 10.1089/hum.2007.177. Hum Gene Ther. 2008. PMID: 18479188

5

Avidin fusion protein-expressing lentiviral vector for targeted drug delivery.

Lesch HP, Pikkarainen JT, Kaikkonen MU, Taavitsainen M, Samaranayake H, Lehtolainen-Dalkilic P, Vuorio T, Määttä AM, Wirth T, Airenne KJ, Ylä-Herttuala S. Lesch HP, et al. Among authors: kaikkonen mu. Hum Gene Ther. 2009 Aug;20(8):871-82. doi: 10.1089/hum.2009.007. Hum Gene Ther. 2009. PMID: 19419273

6

Culture medium induced vimentin reorganization associates with enhanced baculovirus-mediated gene delivery.

Mähönen AJ, Makkonen KE, Laakkonen JP, Ihalainen TO, Kukkonen SP, Kaikkonen MU, Vihinen-Ranta M, Ylä-Herttuala S, Airenne KJ. Mähönen AJ, et al. Among authors: kaikkonen mu. J Biotechnol. 2010 Jan 15;145(2):111-9. doi: 10.1016/j.jbiotec.2009.11.003. Epub 2009 Nov 10. J Biotechnol. 2010. PMID: 19903502

7

Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery.

Kaikkonen MU, Maatta AI, Ylä-Herttuala S, Airenne KJ. Kaikkonen MU, et al. Mol Ther. 2010 May;18(5):987-92. doi: 10.1038/mt.2010.25. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179675 Free PMC article.

8

Avidin-biotin technology in targeted therapy.

Lesch HP, Kaikkonen MU, Pikkarainen JT, Ylä-Herttuala S. Lesch HP, et al. Among authors: kaikkonen mu. Expert Opin Drug Deliv. 2010 May;7(5):551-64. doi: 10.1517/17425241003677749. Expert Opin Drug Deliv. 2010. PMID: 20233034 Review.

9

How to avoid complement attack in baculovirus-mediated gene delivery.

Kaikkonen MU, Ylä-Herttuala S, Airenne KJ. Kaikkonen MU, et al. J Invertebr Pathol. 2011 Jul;107 Suppl:S71-9. doi: 10.1016/j.jip.2011.05.007. J Invertebr Pathol. 2011. PMID: 21784233

10

Baculovirus-mediated vascular endothelial growth factor-D(ΔNΔC) gene transfer induces angiogenesis in rabbit skeletal muscle.

Heikura T, Nieminen T, Roschier MM, Karvinen H, Kaikkonen MU, Mähönen AJ, Lesch HP, Rissanen TT, Laitinen OH, Airenne KJ, Ylä-Herttuala S. Heikura T, et al. Among authors: kaikkonen mu. J Gene Med. 2012 Jan;14(1):35-43. doi: 10.1002/jgm.1637. J Gene Med. 2012. PMID: 22162149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page